allotypic determinants on the same polypeptide. However, some hybrids (15%) show Tthy d coexpression with Tind d or Tsu d. This stable dual expression is reminescent of the B cell that expresses both IgM and IgD (7) . The data are consistent with a maturational model for T cells in which Tthy d antigen is expressed on a precursor cell for the antigen-triggered cells bearing Tsu d and Tindd; evidence for Tsu and Tind being separate lineages of cells is presented. Although the Tthyd-bearing cell may be a precursor for the Tind d and Tsud-bearing cells, it is not a pre-T cell (8, 9) .
Materials and Methods
Mice. C.AL-20 mice, bred at Tufts Medical School since 1978, originated from stock developed by M. Potter, National Institutes of Health, Bethesda, MD. A/J and AKR nude streaker mice (nu/nu and age-matched nu/+) were purchased from The Jackson Laboratory, Bar Harbor, ME. BALB/c AnN animals were purchased from Charles River Breeding Laboratories, Inc., Wilmington, MA.
Production of Monoclonal Cell Lines. Clones of cells producing monoclonal antibodies directed
against T cell products were selected by fusion of BALB/c anti-C.AL-20-immune spleen cells with the BALB/c P.3U1 hypoxanthine, aminopterin, thymidine (HAT)-sensitive cell line (10) . BALB/c AnN males were immunized with C.AL-20 blast cells. Donor cells were stimulated with 5 #g/ml concanavalin A (Con A) for 48 h in complete culture media, harvested, and separated on bovine serum albumin (BSA) discontinuous density gradients (5) . Cells were washed five times in phosphate-buffered saline (PBS), resuspended, and injected intraperitoneally.
Spleen cells from immunized donors were tested between frosted glass slides, erythrocytes (RBC) were lysed with Tris ammonium chloride, and the cells were washed in serum-free media. One spleen equivalent was pelleted with 1.2 × 107 P.3U1 cells in serum-free Dulbecco's H-21. Polyethylene glycol (PEG) (Sigma Chemical Co., St. Louis, MO), 1,000 mol wt, in a 30% solution (0.5 ml), was added to the drained pellets. Cells were resuspended and immediately repelleted by 1,000 g centrifugation at room temperature. PEG was removed, and 10 ml of Dulbecco's H-21 was added slowly over 5 min. Cells were pelleted and resuspended in 60 ml of media, used to maintain the P.3U1 parent line, and incubated at 37°C overnight. On day 1, 1 × 10 -4 M hypoxanthine, 4 × 10 -v M aminopterine and 1.6 × 10 -5 M thymidine were added, and cells were aliquoted into 96-well microtiter plates (Costar Data Packaging, Cambridge, MA). On day 7, cells were fed media containing HAT. Clones were visible on day 8. The fusion frequency was -50% but variable for each fusion.
Tissue culture supernatant was screened for clones secreting antibody by a cell surface radioimmunoassay. Con A was used to activate either BALB/c or C.AL-20 T cells grown in RPMI 1640 with 2% horse serum, not fetal calf serum, which was used in the growth of blast cells for immunization. Con A-activated blast cells were harvested in PBS and washed extensively in serum-free PBS before aliquoting (2 × l0 s cells/100 #1) into each well of a 96-well polyvinyl chloride tray. Plates were centrifuged to increase the adherence of cells, and supernatant was removed. The plates were placed on ice, and 100/~1 of 0.05% glutaraldehyde was added for 5 min and followed by addition of 0.05% ammonium chloride (100 #1) and washed four times with PBS. Horse serum (2% in PBS) (0.04 M NaNs) was added overnight at 4°C. Plates containing either C.AL-20 or BALB/c cells were incubated with tissue culture supernatants (50 ~./well) for 2 h at room temperature. The plates were washed and incubated 125 125 0 with 100/~g of I goat anti-mouse IgGx or I goat anti-mouse IgM overnight at 4 C. Labeled plates were washed in PBS and separated on a hot wire cutter for counting. Positive clones were selected on the basis of binding of the antibody to C.AL-20 ceils and not to BALB/c cells.
Amplification of Antibody-mediated Cell Lysis by Fluorescein Isothiocyanate (FITC)-modified Monoclonal Antibody and Mouse Anti-FITC Immunoglobulin.
Monoclonal antibody was collected from the ascites of mice primed with ~pristane and inoculated with hybrids of P.3U1 and BALB/c AnN anti-C.AL-20-immune cells. Ammonium sulphate-precipitated protein (10 mg/ml) was modified by incubating with 0.5 M sodium carbonate (pH 9.5, containing 10 mg/ml FITC) for 1 h at 4°C. Labeled protein was eluted from a G-25 Sephadex column in 0.1 M sodium phosphate. Antibody was stored at 4°C in 0.04 M NAN,. Limiting dilutions of FITC-modified antibody were incubated with thymoeytes from either C.AL-20 or BALB/c animals for 30 min at 37°C. Affinity-purified mouse antibody specific for FITC was incubated with washed cells for 30 min at 37°C without NaNs, and pelleted cells were resuspended in selected rabbit complement. After incubating at 45°C for 30 min, cells were resuspended in PBS, pelleted, and stored at 4°C, while being scored by eosin red dye exclusion under visual microscopy. FITC anti-Tthy a was used at 0.005 #g/105 cells. This is a 20-fold lower concentration than the unmodified antibody and permitted adsorption by fewer numbers of cells. Data are expressed as cytotoxic index. This represents the percent dead cells in samples treated with antibody and complement minus the percent dead cells in samples treated with complement divided by the percent dead cells in samples treated with rabbit anti-brain-associated thymocyte antigen (BAT) minus the percent dead cells in samples treated with complement times 100%.
Adsorption. Monoclonal antibody modified with FITC (0.005 #g) was incubated with limiting numbers (1 × 106 to 1.5 × 107) of lymphoid cells in an Oudin centrifuge tube (Fisher Scientific Co., Pittsburgh, PA) for 45 min at 4°C. Cells were centrifuged, and clarified supernatant was incubated with target cells to evaluate the extent of depletion of antibody.
BSA Gradient Separation of Thymocyte. The methods used have been described (5 Corp., San Diego, CA) was modified with picrylsulfonic acid (TBNS). Antigen (50 #g in PBS) was emulsified in 50 #1 of complete Freund's adjuvant (CFA; Difco Laboratories, Detroit, MI) and injected into footpads of adult animals on days 0 and 7. The draining popliteal nodes were removed at day 10 and used as targets for antibody-and complement-mediated lysis. (Table I ). However, adsorption of anti-Tind a with thymocytes depletes the lytic antibody tested on antigen-activated popliteal lymph node cells (Fig. 1 ). The absorption with spleen cells parallels that with thymocytes, in contrast to cortisone-resistant thymocytes, which are 10-fold enriched in adsorbing cells (frame A). Anti-Tsu d could also be adsorbed by a comparable number of (11) and complement or anti-rabbit anti-brain-associated antigen (BAT) (12) antibody and complement depletes an adsorbing cell (Table II) . Pretreatment of bone marrow cells with complement and adsorption of anti-Tthy d does remove the lytie activity (reduced from C.I. 17 to C.I. 5), showing that complement above does not lyse this cell. The use of cytotoxic index to display data corrects for spontaneous lysis of thymocytes by complement (5%). Four experiments showing that both anti-BAT and anti-Thy-l.2 lyse the Tthy-bearing cell in marrow were done in doubleblind experiments. In one experiment, anti-Thy-l.2 alone did not block this adsorption. These results might imply that the positive cell in marrow is a recirculating cell because prothymocytes are reputed to be Thy-l.2 negative (8) .
Selection of Fetal
BSA Gradient Fractionation of Tind a-and Tsua-bearing Thymocytes. Discontinuous sedimentation of thymocytes on BSA gradients separates the populations into characteristic groups (13) , which correlates with ability to respond to phytohemagglutinin (PHA) (14) . These groups show differences in the levels of H-2 antigens and Thy-l.2 per cell (15) , and a decrease in surface density might be associated with more "mature" cell populations on the basis of surface characteristics. These characteristic bands suggest there are a small number of thymocytes (2%) that are low density cells expressing Tsu d and/or Tind d but not Tthy d (Table III) .
Antigen-activated Lymph Node T Cells Express Tind a and Tsu a Antigens but Not Tthy a.
Monoelonal antibodies specific for Tthy d, Tind d, and Tsu a do not lyse popliteal lymph node cells from virgin mice. However, secondary immune lymph node cells from footpad-challenged mice can be lysed with antibody and complement (Table IV) . The frequency of Tsu d-or Tindd-expressing cells is not <15% of viable cells on day 3 after a secondary immunization with KLH-TNP in CFA. Tthy d cannot be detected on these cells. When GFA alone was used to inject the mice, increased frequencies of cells expressing Tind or Tsu could not be detected (data not shown). Although CFA contains mycobacterium, a potential antigen, the quantity of antigen might be too low to stimulate T cells.
Spleen cells activated with Con A adsorbed antibody nonspecifically to an extent that did not permit examination of the expression of Tsu d, Tind d, or Tthy d on Bone marrow cells from the AKR 4-/nu str or nuStr/nu str animal were used to adsorb FITC-modified anti-Tthy d monoclonal antibody (Fig. 2) . Cells from the thymus of the heterozygous animal (+/nu str) were used as a positive control. Cells from the nude animal (nuStr/nuStr) failed to adsorb anti-Tthy d in contrast to cells from the heterozygote (+/nu~tr). These data suggest that Tthy a is not a marker for pre-T cells present in the nude animal. Splenic cells from both animals were also used for adSorption; both were negative (data not shown). (Table V) . The lines express these three determinants independently, supporing the concept that these antigens are carried on separate structural products, in contrast to the possibility that they might be three antigenic sites on the same molecule. The 27 lines typed showed random association between Lyt-1 and Lyt-2 and these antigens. We had reported earlier ( :~ Four lines were positive for both Tthy and Tsu or Tind. This dual expression in JT~9 has been maintained for 9 mo in vitro and appears to be a stable characteristic of the cell.
Expression of Tind d, Tthy d, and Tsu d Alloantigens on Hybrid T Cell Lines Constructed
neonatal thymocytes were used to adsorb anti-Tthy a and the residual antibody was scored on adult thymocytes, Tthy a could be detected on days 1-2 (Fig. 3, frame B) .
It is possible that Tthy a is expressed on fetal thymocytes as a surface determinant but our assay is too insensitive to detect these determinants. One might predict a gradual increase in surface density as the positive cells appear in ontogeny. There is a linear increase in the percentage of positive cells between day 2 and day 5 (Fig. 3, frame A) . from fusion of BW5147 with fetal liver cells are reported in Table VI . It is possible that these cells are precursor T cells because one line expresses Thy-l.2 with high densities at all times in the cell cycle, one is negative for Thy-1.2, but both fail to have detectable levels of Lyt-1 and Lyt-2. However, the ability to express Lyt-1 and Lyt-2 could be dependent, either directly or indirectly, upon the expression of chromosomes that are lost in these hybrid lines. All the fetal lines experienced 4-wk crisis periods early in establishment. Similarly, only one of the three lines that originated from fetal thymus fusion with BW5147 expressed Lyt-l.2. Because Thy-l.2 and Lyt-l.2 should be expressed on fetal thymocytes at 17 d, it is unclear why our hybrids do not display these antigens. This might be a result of the statistical frequency of positive cells, BW5147 might have a preferential fusion partner, or Lyt-l.2 might be on a chromo- some that segregates and is easily lost. Tind a is expressed on neonatal splenic cells at days 2-3 (Fig. 4, frame A) . AntiTind a can be adsorbed by 5 x 10 6 neonatal spleen cells, and the lytic activity of that antibody on antigen-activated popliteal node cells is depleted by day-2 cells. In contrast, anti-Tsu a could not be adsorbed by splenic T cells (5 × 10 6) until days 5-6 postnatally (Fig. 4, frame B) .
Discussion
If multiple isotypes of T cell receptors exist (1), then the expression of distinct isotypes might be characteristic of the maturational level of the cell and not the functional subpopulation (18) . B lymphocytes have been shown to undergo a differentiation pathway from IgM ---* IgM + IgD --~ IgD or IgG (19) in response to antigenic pressures. It is possible that T cells undergo a similar pathway in which a primitive receptor-bearing cell is the precursor (pre-T) for all T cells. As that cell matures ontogenetically and functionally, it might acquire new isotypes that make it functionally more efficient (20) .
Fetal thymocytes express receptors for alloantigens. At day 14 of gestation, thymocyte precursors for CTL-or MLR-alloreactive cells exist, and these cells can mature functionally in organ cultures (21, 22) . These are the earliest known T cell functions (6) . Because alloreactivity parallels the development of the thymic rudiment (23) and the earliest expression of Thy-l.2 (24), the antigen receptor on alloreactive T cells could be considered the primitive T cell ~ analogue. In contrast to these data, we found that One would predict that a fetal T cell should express that isotype by day 15 in gestation and that the precursor for the cytotoxic T cell in nude animals might retain that isotype.
That T cell receptor isotypes are characteristic of functionally diverse cells has been hypothesized (1, 25) . This speculation is based on experimental data showing that Tsu and Tind are preferentially expressed on either Lyt-2 or Lyt-1 cells (1, 2) and on the finding that antisera made with a similar immunization protocol distinguishes between antigen:specific augmenting and suppressing factors (26) . Contrasting data from the studies of Binz and Wigzell (27) show that alloreactive antigen receptors on Lyt-1-and Lyt-2-bearing cells are identical. These data are compatible when functional diversification occurs before receptor isotype acquisition. It is possible that the T cell lineage is branched; a pre-T cell could mature into a cytotoxic precursor (Tpc) and, from that line, a group of regulatory cells (Ts, Th, Tind) could diverge. If Ts, Tc, Th develop in ontogeny much later than To, the receptor isotypes could be acquired after Lyt-1-and Lyt-2-bearing cells functionally diversify (28) . The isotypes of the late-maturing population would appear to be distinctive of the Lyt functional type, whereas an early maturing alloreactive cell would use the same isotypes for Lyt-1 or Lyt-2 cells. If one isotype is more efficient for a particular functional cell, antigenic pressures would expand the most appropriate clone. One would expect to see T suppressor cells with a spectrum of isotypes, one of which might predominate because these clones have been selectively expanded. In nature, one might expect to see most suppressor receptors associated with the Tsu isotype, whereas individual clones, some of which would be functionally more competent, would have random isotypes.
The latter interpretation fits the data obtained with our T cell hybrids. In the 27 clones examined, cells express either Tsu or Tind. No clone showed simultaneous expression of both antigens, although 3 of 27 clones showed Tthy d co-expressed with Tsu or Tind. These data are consistent with our initial observations that Tsu-bearing cells and Tind cells represent two separate lineages of cells and that the Tthy population may be a precursor for both these cells. Tsu and Tind show random association with Lyt-1 or Lyt-2 in the hybrids. No functional data is available for these clones. It is possible that association of an appropriate T cell isotype with an appropriate I-A or I-J phenotype is necessary for function (29) (30) . I region-encoded products may contribute to the quaternary structure of these polypeptides. If this is the case, many of our hybrids may be nonfunctional; only a clone that has the appropriate random association of Tind, I-A, and/or Lyt-1 chains would be biologically functional. This model necessitates waste of many precursor clones that might have the appropriate variable region specificity but does account for the observed Iaassociated restrictions on T cell factors.
Some of our "T cell" hybrids (Table V) do not express Tthy-1.2. It is possible that segregation of chromosomes takes place, independently leading to loss of Thy-l.2, Lyt-1.2, and Lyt-2.2. These clones were selected for expression of Tsu, Tind, or Tthy. None express surface immunoglobulin. Mature T cells are frequently low theta dense, and the hybrids might have few alloantigens per cell, escaping detection by direct lysis. The surface expression ofTsu, Tind, and Tthy is a stable phenotype; chromosome 12 may be vital for growth of the cell and, therefore, would not be deleted in viable cells.
The maturational schemata for T cells (Fig. 5) illustrates the acquisition of Tthy, Tind, or Tsu at characteristic points in development. Many thymocytes express Tthy d (35% C.I.), although it is a subpopulation marker. Studies of Keese and Owen show that this is not a determinant on all cells in the thymus. Both cortisone-sensitive and -resistant cells express Tthy d, although a low density thymocyte, which is Thy-l.2 sparse and H-2k dense, lacks this antigen. Cortisone-resistant thymocytes, in contrast, express Tind and Tsu. Tsu is preferentially expressed on thymocytes in the least dense BSA fraction. As cells exit th e thymus, Tthy is lost. We know it must be present genetically in some of the cells in the periphery because our hybrids, which originate from lymph node, rescue this specificity. This might be due to genetic complementation, assuming Tthy d is not deleted, and Tthy d need not be assumed to be a surface marker in lymph node in vivo for the results to be consistent. Resting spleen cells can adsorb Tsu and Tind but the frequency of cells and/or density of antigen per cell prevents visualization of direct killing. In contrast, 15-20% of popliteal node cells from antigen-primed, footpad challenged mice express Tind or Tsu. The populations appear to be numerically nonoverlapping. Tthy-, Tind-, and Tsu-bearing populations might represent a progression of cells undergoing differentiation pressures, which parallel acquisition of immunocompetence.
B lymphocytes express surface isotypes after antigenic maturation in a preprogrammed order that follows the order of the constant region genes on chromosome 12 ;> O Z (~ ?~ y~ ~'1 y2b 72a a E) (31) . That same order is followed in the ontological expression of the isotypes (7). It is possible that variable region genes must be translocated sequentially by inserting into characteristic switch sites rather than being randomly translocated to a constant region gene downstream from/~. The order of expression of Tthy d, Tind d, and Tsu a on maturing T cells (not proven to be antigen triggered) also parallels the ontological order of appearance of these antigens. This suggests a similar organization of genes within a T cell-receptor gene complex. Because cDNA probes
do not yet exist for T cell-constant regions, one can only speculate that a mechanism for biological preservation of VH genes could dictate the use of characteristic switch mechanism for T cell antigen receptors.
Summary
Monoclonal antibodies specific for three T cell alloantigens linked to the immunoglobulin complex on chromosome 12 were used to establish the order of expression of these antigens on immunocompetent cells and in ontogeny. Modification of monoclonal antibodies with fluorescein isothiocyanate (FITC) and use with anti-FITC and complement has amplified lytic capacity of the monoclonals and allowed us to complete a distribution study of Tsu a, Tind d, and Tthy d alloantigens on immunocompetent cells. Tthy d is expressed on both cortisone-sensitive and cortisoneresistant thymocytes; Tsu d and Tind d are on "mature" cortisone-resistant cells. Tthy d is also expressed on a Thy-l.2-bearing recirculating marrow cell but is undetectable in the peripheral T cell pool. In contrast, resting spleen and lymph node T cells express Tsu d and Tindd; antigen-activated populations express these two cells in high frequencies. These antigens must be markers for relatively differentiated cells because "nude" animals, which have pre-T cells, fail to express these determinants. All three antigens segregate independently in our T cell hybrids, arising from adult peripheral node cells, supporting the hypothesis that these are three separate structural products of a gene complex. In contrast, fetal T cell hybrids fail to express these antigens. The appearance of all three antigens on the cell surface in ontogeny is postnatal; Tthy d is expressed at days 1-2, Tind d at days 2-3, and Tsu d at days [5] [6] . If the T cell isotype genes are organized similar to the immunoglobulin loci, then the parallels in maturational expression on immunocompetent cells and in ontogeny would lead one to speculate a gene order of Tthy d ~ Tind d --> Tsu d. Orientation with respect to the centromere is unknown.
